Intensive Prevention Program After Myocardial Infarction (IPP)
Myocardial Infarction, Prevention Harmful Effects
About this trial
This is an interventional prevention trial for Myocardial Infarction
Eligibility Criteria
Inclusion Criteria:
Hospitalisation due to myocardial infarction (ST-elevation or non-ST-elevation myocardial infarction)
Exclusion Criteria:
i) Hemodynamically significant valvular heart disease (> NYHA class II) or inborn cardiac malformations.
ii) Cardiomyopathy associated with hemodynamic obstruction, pregnancy or myocarditis.
iii) Exercise limitations due to clinical conditions not related to CAD. iv) Any major non-cardiac condition that would adversely effect survival during the duration of the study.
v) Patients unlikely to comply to the study treatment and the follow-up visits. vi) Pregnancy (all pre-menopausal females should have a negative serum pregnancy test).
vii) Inability of cooperation with the protocol, including longterm follow-up. viii) Patient refusal or inability to give informed consent. ix) Refusal of the patient's physician regarding trial participation of the patient.
x) Chronic drug or alcohol abuse.
Sites / Locations
- Herzzentrum Bremen
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Intensive prevention program
Usual care
Standard care with respect to medical and interventional therapy plus intensive prevention program with "study nurse"-coordinated education sessions, regular telephone calls, telephone hotline and telemetric care of cardiovascular risk factors (if patient internet connection available).
Standard care with respect to medical and interventional therapy.